WSWilma T. Steegenga

Wilma T. Steegenga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wilma T. Steegenga has a total of 118 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Colon-delivered multivitamin supplementation enhances working memory-related fMRI responses in older adults: a randomized, placebo-controlled trial

    by Lianne B. Remie, Mark R. van Loenen, Mechteld M. Grootte Bromhaar, Noortje M.P. Overwater, Janne van Overbeek, Andrea Anesi, Urska Vrhovsek, Ateequr Rehman, Robert E. Steinert, Jurriaan J. Mes, et al.

    Background: Vitamins are important modulators of intestinal health and may affect the gut-brain axis through microbial metabolites such as short-chain fatty acids (SCFAs). However, the neurocognitive effects of colon-delivered vitamins in older adults remain unexplored − a critical gap given the gut-brain axis9s emerging role in cognitive aging. Objective: We investigated the effect of a colon-delivered multivitamin (CDMV) supplement on intestinal health and neurocognitive outcomes in older adults at risk of cognitive decline. Methods: Within the double-blind randomized placebo-controlled trial COMBI (ClinicalTrials.govID: NCT05675007), we included 75 older adults (60-75 years) at risk of cognitive decline based on lifestyle-related factors. Participants consumed a colon-delivered capsule with vitamins B2, B3, B6, B9, C and D3, or a placebo, daily for six weeks. Pre- and post-intervention, we employed neuroimaging, feces- and blood collection. Primary outcomes were fecal SCFA concentrations, working memory (WM)-related fMRI responses, and WM performance measured with the n-back task. Results: After adjusting for baseline values, we found no significant between-group differences in total fecal SCFA levels (p = 0.30) and WM performance (p = 0.50). Post-intervention WM-related fMRI responses in the hippocampus (p = 0.01; ηp2 = 0.09) and dorsolateral prefrontal cortex (dlPFC) (p = 0.06; ηp2 = 0.04), driven by the right dlPFC (p = 0.02), were higher in the CDMV group compared to placebo. Independent of intervention group, post-pre increases in fecal SCFA levels were significantly correlated to increases in dlPFC fMRI responses (ρ = 0.31; p = 0.02) and WM performance (ρ = 0.43; p = 0.001). Conclusions: Our findings suggest that CDMV supplementation increases WM-related responses of the dlPFC and hippocampus in older adults, but this effect was not accompanied by changes in fecal SCFA levels or WM performance. The positive correlation of within-subject changes in fecal SCFAs with changes in WM dlPFC responses and performance across intervention groups provides human evidence for gut-brain communication in cognitive aging beyond cross-sectional associations.

  • Open Access

    The effects of a multidomain lifestyle intervention on brain functioning and its relation with immunometabolic markers and intestinal health in older adults at-risk of cognitive decline: study design and baseline characteristics of the HELI randomized controlled trial. (Preprint)

    by Mark R. van Loenen, Lianne B. Remie, Mara P.H. van Trijp, Michelle G. Jansen, José P. Marques, Jurgen A.H.R. Claassen, Ondine van de Rest, Yannick Vermeiren, Nynke Smidt, Sietske A.M. Sikkes, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Studies of multidomain lifestyle interventions show mixed results on preventing or delaying cognitive decline in ageing. A better understanding of the mechanisms underlying these interventions could help explain these mixed findings. Objective: The HELI study aims to investigate the brain and peripheral mechanisms of a multidomain lifestyle intervention in older adults at risk of cognitive decline. Methods: The HELI study is a 6-month multicentre, randomized, controlled multidomain lifestyle intervention trial powered to include 104 Dutch older adults at risk of cognitive decline. Individuals were deemed at risk when scoring ≥2 points on a lifestyle-modifiable risk factor scale (e.g. overweight, physical inactivity, hypertension, hypercholesterolemia). The multidomain lifestyle intervention consisted of five domains (diet, physical activity, stress management/mindfulness, cognitive training, and sleep) and participants were randomized in one of two intervention groups: (1) a high-intensity coaching group consisting of weekly supervised online and on-site group meetings, exercises and learning materials from lifestyle-specific course modules, and (2) a low-intensity coaching group consisting of general lifestyle-related health information sent through e-mail every two weeks. The primary study outcomes are changes between baseline and 6-month follow-up in (1) brain activation in dorsolateral prefrontal cortex (dlPFC) and hippocampus and task accuracy during an fMRI working memory task (2) ASL-quantified cerebral blood flow in dlPFC and hippocampus, (3) systemic inflammation from blood plasma (IL-6, TNF-α, hs-CRP) and (4) microbiota profile from faeces (gut microbiome diversity (Shannon and phylogenetic diversity) and richness (Chao1)). In addition, we will investigate intervention-induced gut-immune-brain links by assessing the relation between the effects found in the aforementioned primary brain and gut outcome measures. Secondary study outcomes include (1) structural and neurochemical MRI, (2) anthropometric measurements, (3) neuropsychological test battery scores, (4) lifestyle-domain related measures from questionnaire scores and a smartwatch, and an array of peripheral measures from (5) faecal analysis, (6) blood analysis, and (7) breath analysis. Results: Between April 2022 and October 2023 we have successfully included n = 102 older Dutch adults (mean age: 66.6 (SD: 4.3) years; 65.7% female) with ≥2 lifestyle-modifiable risk factors of cognitive ageing (median risk: 3 (IQR: 2, 3)). The most common self-reported lifestyle-modifiable risk factors of cognitive ageing at baseline were overweight or obesity (74.5%), followed by hypertension (56.9%), hypercholesterolemia (55.9%), and physical inactivity (55.9%). Conclusions: The HELI study aims to enhance our understanding of working mechanisms of multidomain lifestyle interventions through its comprehensive characterization of central and peripheral markers. We intend to achieve this aim by assessing lifestyle intervention-induced changes in functional and structural MRI brain measures, as well as peripheral measures of the gut-immune-brain axis involved in cognitive ageing. Clinical Trial: ClinicalTrials.gov ID NCT05777863 ToetsingOnline.nl filenumber NL78263.091.21


  • Open Access

    The effects of a multidomain lifestyle intervention on brain functioning and its relation with immunometabolic markers and intestinal health in older adults at-risk of cognitive ageing: study design and baseline characteristics of the HELI randomized controlled trial (Preprint)

    by Mark R. van Loenen, Lianne B. Remie, Mara P.H. van Trijp, Michelle G. Jansen, José P. Marques, Jurgen A.H.R. Claassen, Ondine van de Rest, Yannick Vermeiren, Nynke Smidt, Sietske A.M. Sikkes, et al.

    BACKGROUND Studies of multidomain lifestyle interventions show mixed results on preventing or delaying cognitive decline in ageing. A better understanding of the mechanisms underlying these interventions could help explain these mixed findings. OBJECTIVE The HELI study aims to investigate the brain and peripheral mechanisms of a multidomain lifestyle intervention in older adults at risk of cognitive decline. METHODS The HELI study is a 6-month multicentre, randomized, controlled multidomain lifestyle intervention trial powered to include 104 Dutch older adults at risk of cognitive decline. Individuals were deemed at risk when scoring ≥2 points on a lifestyle-modifiable risk factor scale (e.g. overweight, physical inactivity, hypertension, hypercholesterolemia). The multidomain lifestyle intervention consisted of five domains (diet, physical activity, stress management/mindfulness, cognitive training, and sleep) and participants were randomized in one of two intervention groups: (1) a high-intensity coaching group consisting of weekly supervised online and on-site group meetings, exercises and learning materials from lifestyle-specific course modules, and (2) a low-intensity coaching group consisting of general lifestyle-related health information sent through e-mail every two weeks. The primary study outcomes are changes between baseline and 6-month follow-up in (1) brain activation in dorsolateral prefrontal cortex (dlPFC) and hippocampus and task accuracy during an fMRI working memory task (2) ASL-quantified cerebral blood flow in dlPFC and hippocampus, (3) systemic inflammation from blood plasma (IL-6, TNF-α, hs-CRP) and (4) microbiota profile from faeces (gut microbiome diversity (Shannon and phylogenetic diversity) and richness (Chao1)). In addition, we will investigate intervention-induced gut-immune-brain links by assessing the relation between the effects found in the aforementioned primary brain and gut outcome measures. Secondary study outcomes include (1) structural and neurochemical MRI, (2) anthropometric measurements, (3) neuropsychological test battery scores, (4) lifestyle-domain related measures from questionnaire scores and a smartwatch, and an array of peripheral measures from (5) faecal analysis, (6) blood analysis, and (7) breath analysis. RESULTS Between April 2022 and October 2023 we have successfully included n = 102 older Dutch adults (mean age: 66.6 (SD: 4.3) years; 65.7% female) with ≥2 lifestyle-modifiable risk factors of cognitive ageing (median risk: 3 (IQR: 2, 3)). The most common self-reported lifestyle-modifiable risk factors of cognitive ageing at baseline were overweight or obesity (74.5%), followed by hypertension (56.9%), hypercholesterolemia (55.9%), and physical inactivity (55.9%). CONCLUSIONS The HELI study aims to enhance our understanding of working mechanisms of multidomain lifestyle interventions through its comprehensive characterization of central and peripheral markers. We intend to achieve this aim by assessing lifestyle intervention-induced changes in functional and structural MRI brain measures, as well as peripheral measures of the gut-immune-brain axis involved in cognitive ageing. CLINICALTRIAL ClinicalTrials.gov ID NCT05777863 ToetsingOnline.nl filenumber NL78263.091.21


  • Open Access

    Human gut microbiota composition and its predicted functional properties in people with western and healthy dietary patterns

    by Anna M. Malinowska, Dieuwertje E. Kok, Wilma T. Steegenga, Guido J. E. J. Hooiveld, Agata Chmurzynska

    Purpose: Some dietary habits cluster together, and for this reason it is advised to study the impact of entire dietary patterns on human health, rather than that of individual dietary habits. The main objective of this study was to evaluate differences in gut microbiota composition and their predicted functional properties between people with a healthy (HDP) and western (WDP) dietary pattern. Methods: A cross-sectional, observational study was carried out on 200 participants enrolled 2017–2018 in Poznań, Poland, equally distributed into HDP and WDP groups. Diet was estimated using 3-day food records and information on stool transit times was collected. Fecal microbiota composition was assessed by 16S rRNA gene sequencing and its functional properties were predicted by the PICRUSt2 workflow. Results: The α-diversity did not differ between people with WDP and HDP, but β-diversity was associated with dietary pattern. People with HDP had higher relative abundances (RA) of Firmicutes and Faecalibacterium and lower RA of Bacteroidota and Escherichia–Shigella than participants with WDP. Only a small proportion of the variance in microbiota composition (1.8%) and its functional properties (2.9%) could be explained by dietary intake (legumes, simple sugars and their sources, like fruit, soft drinks) and stool transit characteristics. Conclusion: Gut microbiota composition and predicted metabolic potential is shaped by overall diet quality as well as the frequency of defecation; however, the cumulative effect of these explain only a relatively low proportion of variance.


  • Open Access

    The effects of sulfated secondary bile acids on intestinal barrier function and immune response in an inflammatory in vitro human intestinal model

    by Benthe van der Lugt, Maartje C.P. Vos, Mechteld Grootte Bromhaar, Noortje Ijssennagger, Frank Vrieling, Jocelijn Meijerink, Wilma T. Steegenga


  • Open Access

    Akkermansia muciniphila ameliorates the age-related decline in colonic mucus thickness and attenuates immune activation in accelerated aging Ercc1−/Δ7 mice

    by Benthe van der Lugt, Adriaan A. van Beek, Steven Aalvink, Ben Meijer, Bruno Sovran, Wilbert P. Vermeij, Renata M. C. Brandt, Willem M. de Vos, Huub F. J. Savelkoul, Wilma T. Steegenga, et al.

    The use of Akkermansia muciniphila as potential therapeutic intervention is receiving increasing attention. Health benefits attributed to this bacterium include an improvement of metabolic disorders and exerting anti-inflammatory effects. The abundance of A. muciniphila is associated with a healthy gut in early mid- and later life. However, the effects of A. muciniphila on a decline in intestinal health during the aging process are not investigated yet. We supplemented accelerated aging Ercc1−/Δ7 mice with A. muciniphila for 10 weeks and investigated histological, transcriptional and immunological aspects of intestinal health. The thickness of the colonic mucus layer increased about 3-fold after long-term A. muciniphila supplementation and was even significantly thicker compared to mice supplemented with Lactobacillus plantarum WCFS1. Colonic gene expression profiles pointed towards a decreased expression of genes and pathways related to inflammation and immune function, and suggested a decreased presence of B cells in colon. Total B cell frequencies in spleen and mesenteric lymph nodes were not altered after A. muciniphila supplementation. Mature and immature B cell frequencies in bone marrow were increased, whereas B cell precursors were unaffected. These findings implicate that B cell migration rather than production was affected by A. muciniphila supplementation. Gene expression profiles in ileum pointed toward a decrease in metabolic- and immune-related processes and antimicrobial peptide production after A. muciniphila supplementation. Besides, A. muciniphila decreased the frequency of activated CD80+CD273− B cells in Peyer’s patches. Additionally, the increased numbers of peritoneal resident macrophages and a decrease in Ly6Cint monocyte frequencies in spleen and mesenteric lymph nodes add evidence for the potentially anti-inflammatory properties of A. muciniphila. Altogether, we show that supplementation with A. muciniphila prevented the age-related decline in thickness of the colonic mucus layer and attenuated inflammation and immune-related processes at old age. This study implies that A. muciniphila supplementation can contribute to a promotion of healthy aging.


  • Open Access

    Lifelong calorie restriction affects indicators of colonic health in aging C57Bl/6J mice

    by Dieuwertje E.G. Kok, Fenni Rusli, Benthe van der Lugt, Carolien Lute, Luca Laghi, Stefano Salvioli, Gianfranco Picone, Claudio Franceschi, Hauke Smidt, Jacques Vervoort, et al.


  • Open Access

    Plasticity of lifelong calorie‐restricted C57BL/6J mice in adapting to a medium‐fat diet intervention at old age

    by Fenni Rusli, Mark V. Boekschoten, Vincenzo Borelli, Chen Sun, Carolien Lute, Aswin L. Menke, Joost van Den Heuvel, Stefano Salvioli, Claudio Franceschi, Michael Müller, et al.

    Summary: Calorie restriction (CR) is a dietary regimen that supports healthy aging. In this study, we investigated the systemic and liver‐specific responses caused by a diet switch to a medium‐fat (MF) diet in 24‐month‐old lifelong, CR‐exposed mice. This study aimed to increase the knowledge base on dietary alterations of gerontological relevance. Nine‐week‐old C57BL/6J mice were exposed either to a control, CR, or MF diet. At the age of 24 months, a subset of mice of the CR group was transferred to ad libitumMF feeding (CR‐MF). The mice were sacrificed at the age of 28 months, and then, biochemical and molecular analyses were performed. Our results showed that, despite the long‐term exposure to the CR regimen, mice in the CR‐MF group displayed hyperphagia, rapid weight gain, and hepatic steatosis. However, no hepatic fibrosis/injury or alteration in CR‐improved survival was observed in the diet switch group. The liver transcriptomic profile of CR‐MF mice largely shifted to a profile similar to the MF‐fed animals but leaving ~22% of the 1,578 differentially regulated genes between the CR and MF diet groups comparable with the expression of the lifelong CR group. Therefore, although the diet switch was performed at an old age, the CR‐MF‐exposed mice showed plasticity in coping with the challenge of a MF diet without developing severe liver pathologies.


  • Open Access

    Persistent organic pollutants alter DNA methylation during human adipocyte differentiation

    by Myrthe W. van Den Dungen, Albertinka J. Murk, Dieuwertje E. Kok, Wilma T. Steegenga


  • Open Access

    Intermittent calorie restriction largely counteracts the adverse health effects of a moderate‐fat diet in aging C57BL/6J mice

    by Fenni Rusli, Carolien Lute, Mark V. Boekschoten, Miriam van Dijk, Klaske van Norren, Aswin L. Menke, Michael Müller, Wilma T. Steegenga

    : Calorie restriction (CR) has been shown to extend life- and health-span in model species. For most humans, a life-long CR diet is too arduous to adhere to. The aim of this study was to explore whether weekly intermittent CR can 1) provide long-term beneficial effects and 2) counteract diet-induced obesity in male aging mice. : In this study we have exposed C57Bl/6J mice for 24 months to an intermittent (INT) diet, alternating weekly between CR of a control diet and ad libitum moderate-fat (MF) feeding. This weekly intermittent CR significantly counteracted the adverse effects of the MF diet on mortality, body weight and liver health markers in male 24-month-old mice. Hepatic gene expression profiles of INT-exposed animals appeared much more comparable to CR than to MF-exposed mice. At 12 months of age, a subgroup of MF-exposed mice was transferred to the INT diet. Gene expression profiles in the liver of the 24-month-old diet switch mice were highly similar to the INT-exposed mice. However, a small subset of genes was consistently changed by the MF diet during the first phase of life. : Weekly intermittent CR largely, but not completely, reversed adverse effects caused by a MF diet. This article is protected by copyright. All rights reserved